Leadership
Medtronic has appointed Dev Mertia as Senior Director of Strategy, Transformation & Commercial Operations for its Electrophysiology Therapies Operating Unit in Western Europe, effective October 2026. In his new role, Dev will help shape strategic direction, drive organizational integration and strengthen commercial execution following the June 2026 combination of the Cardiac Rhythm Management and Cardiac Ablation Solutions businesses.
Dev brings extensive experience across strategy, finance, commercial operations and business transformation, built over more than two decades in leadership roles at Medtronic. Most recently, he served as Director of Strategy, Integrated Business Planning and Commercial Operations for Western Europe, where he led strategic planning, forecasting, operational excellence and commercial initiatives.
Previously, he served as Director of Finance for Europe, the Middle East and Africa, holding CFO responsibilities across multiple cardiovascular businesses. His earlier experience includes regional financial planning and analysis leadership at Medtronic and finance roles at Johnson & Johnson.
In his expanded role, Dev will focus on go-to-market strategies, governance, integrated business planning, operational efficiency and strengthening data-driven, AI-ready commercial operations.
CXO TechBOT congratulates Dev Mertia on his new leadership role and wishes him continued success at Medtronic.
